Flow Cytometers
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
1,707
NCT02155426
Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
Phase: N/A
Role: Collaborator
Start: Apr 30, 2014
Completion: Dec 31, 2016
NCT03647215
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
Role: Lead Sponsor
Start: Dec 18, 2017
Completion: Jun 30, 2021
NCT04160546
Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
Phase: Phase 2
Start: Jan 17, 2020
Completion: Dec 31, 2025
Loading map...